SfE is grateful to our Society Partners, Corporate Sponsors and Exhibitors whose regular participation always helps to make SfE BES a success

Society Partners

By partnering with your extraordinary community, HRA Pharma Rare Diseases has a personal commitment to playing our part in tackling current challenges, reducing the time to accurate diagnosis, enabling global access to treatment and optimising long-term management.

We share your purpose: to improve the quality of life and the experience of care for families affected by rare diseases.

For more information on HRA Pharma Rare Diseases please email [email protected] or telephone 0800 917 9548.

Pfizer is the world’s largest research-based pharmaceutical company. Our goal is to discover, develop, manufacture and deliver quality, effective prescription medicines to treat and help prevent disease.

Pfizer has an excellent heritage in endocrinology and remains highly committed to its endocrine product portfolio. The company is an industry leader in long term surveillance studies in endocrinology and has an active Investigator-Initiated Research program supporting advances in medical and scientific knowledge.

For more information on Pfizer, visit our website at www.pfizer.co.uk/.

At Recordati Rare Diseases UK, we focus on the few - those affected by rare diseases. We believe that health, and the opportunity to live life to the fullest, is a right, not a privilege. We want to give people the opportunity to unlock the full potential of life.

Many diseases may impact how the varied endocrine glands work in the body, resulting in disordered hormone production and secretion, which may underlie burdensome, and in some cases, life-threatening syndromes and conditions if left untreated.

For more information on Recordati Rare Diseases, please visit our website at https://www.recordatirarediseases.uk or email us at [email protected]

Sandoz is a global leader in generic and biosimilar medicines, committed to playing a leading role in driving access to medicine worldwide.

Sandoz, a Division of the Novartis Group, is a global leader in generic and biosimilar medicines. Sandoz contributes to society’s ability to support growing healthcare needs by pioneering novel approaches to help people around the world access high-quality medicine.

For more information on Sandoz, visit www.sandoz.com/

Supporters